Patents Represented by Law Firm Mueting, Baasch, Gebhardt & Schwappach, P.A.
  • Positively charged oligonucleotides as regulators of gene expression
    Patent number: 5734040
    Abstract: This invention relates to oligonucleotides with ethylenediamine phosphoramidate internucleoside linkages useful for binding to eukaryotic duplex DNA to inhibit or alter gene expression.
    Type: Grant
    Filed: March 21, 1996
    Date of Patent: March 31, 1998
    Assignee: University of Iowa Research Foundation
    Inventors: Daniel L. Weeks, John Dagle